Oral retinoids and depression: reply from the authors

Linked Articles: Lehloenya and Jessop. Br J Dermatol 2018; 178:1223–1224. Vallerand and Patten. Br J Dermatol 2018; 178:305. Le Moigne et al. Br J Dermatol 2018; 178:278–280

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of dermatology (1951) 2018-05, Vol.178 (5), p.1224-1224
Hauptverfasser:	Le Moigne, M., Fournier, J.‐P., Victorri‐Vigneau, C., Dréno, B.
Format:	Artikel
Sprache:	eng
Schlagworte:	Cancer Life Sciences Mental depression Retinoids
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	1224
container_issue	5
container_start_page	1224
container_title	British journal of dermatology (1951)
container_volume	178
creator	Le Moigne, M. Fournier, J.‐P. Victorri‐Vigneau, C. Dréno, B.
description	Linked Articles: Lehloenya and Jessop. Br J Dermatol 2018; 178:1223–1224. Vallerand and Patten. Br J Dermatol 2018; 178:305. Le Moigne et al. Br J Dermatol 2018; 178:278–280
doi_str_mv	10.1111/bjd.16429
format	Article
fullrecord	<record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_inserm_02913583v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2042017215</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3909-e1ff92de23bfefa28d3a71f4974c8b4182e6b3b8ca4cab68e887ec87f88a76013</originalsourceid><addsrcrecordid>eNp10LtOwzAUBmALgaAUBl4ARWIBibS-5GKzlXIpqFIXmC0nOVZTJXGxE1DfHpeUDkh4OYM__TrnR-iC4BHxb5ytihFJIioO0ICwJA4pYewQDTDGaYhFwk7QqXMrjAnDMT5GJ1REOKZxMkDxwqoqsNCWjSkLF6imCApYW3CuNM2d_1lXm0BbUwftEgLVtUtj3Rk60qpycL6bQ_T-9Pg2nYXzxfPLdDIPcyawCIFoLWgBlGUatKK8YColOhJplPMsIpxCkrGM5yrKVZZw4DyFnKeac5Umftshuu1zl6qSa1vWym6kUaWcTeaybBzYWmIqCIs5-9zy656vrfnowLWyLl0OVaUaMJ2TRIiYxMxX5enVH7oynW38MZLiiGKSUi-H6KZXuTXOWdD7JQiW2-qlr17-VO_t5S6xy2oo9vK3aw_GPfgqK9j8nyTvXx_6yG-a1IsH</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2042017215</pqid></control><display><type>article</type><title>Oral retinoids and depression: reply from the authors</title><source>Wiley Journals</source><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Le Moigne, M. ; Fournier, J.‐P. ; Victorri‐Vigneau, C. ; Dréno, B.</creator><creatorcontrib>Le Moigne, M. ; Fournier, J.‐P. ; Victorri‐Vigneau, C. ; Dréno, B.</creatorcontrib><description>Linked Articles: Lehloenya and Jessop. Br J Dermatol 2018; 178:1223–1224. Vallerand and Patten. Br J Dermatol 2018; 178:305. Le Moigne et al. Br J Dermatol 2018; 178:278–280</description><identifier>ISSN: 0007-0963</identifier><identifier>EISSN: 1365-2133</identifier><identifier>DOI: 10.1111/bjd.16429</identifier><identifier>PMID: 29405256</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Cancer ; Life Sciences ; Mental depression ; Retinoids</subject><ispartof>British journal of dermatology (1951), 2018-05, Vol.178 (5), p.1224-1224</ispartof><rights>2018 British Association of Dermatologists</rights><rights>Copyright © 2018 British Association of Dermatologists</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3909-e1ff92de23bfefa28d3a71f4974c8b4182e6b3b8ca4cab68e887ec87f88a76013</citedby><cites>FETCH-LOGICAL-c3909-e1ff92de23bfefa28d3a71f4974c8b4182e6b3b8ca4cab68e887ec87f88a76013</cites><orcidid>0000-0002-3745-2532 ; 0000-0001-5574-5825 ; 0000-0002-9971-0672</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fbjd.16429$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fbjd.16429$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,780,784,885,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29405256$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://inserm.hal.science/inserm-02913583$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Le Moigne, M.</creatorcontrib><creatorcontrib>Fournier, J.‐P.</creatorcontrib><creatorcontrib>Victorri‐Vigneau, C.</creatorcontrib><creatorcontrib>Dréno, B.</creatorcontrib><title>Oral retinoids and depression: reply from the authors</title><title>British journal of dermatology (1951)</title><addtitle>Br J Dermatol</addtitle><description>Linked Articles: Lehloenya and Jessop. Br J Dermatol 2018; 178:1223–1224. Vallerand and Patten. Br J Dermatol 2018; 178:305. Le Moigne et al. Br J Dermatol 2018; 178:278–280</description><subject>Cancer</subject><subject>Life Sciences</subject><subject>Mental depression</subject><subject>Retinoids</subject><issn>0007-0963</issn><issn>1365-2133</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp10LtOwzAUBmALgaAUBl4ARWIBibS-5GKzlXIpqFIXmC0nOVZTJXGxE1DfHpeUDkh4OYM__TrnR-iC4BHxb5ytihFJIioO0ICwJA4pYewQDTDGaYhFwk7QqXMrjAnDMT5GJ1REOKZxMkDxwqoqsNCWjSkLF6imCApYW3CuNM2d_1lXm0BbUwftEgLVtUtj3Rk60qpycL6bQ_T-9Pg2nYXzxfPLdDIPcyawCIFoLWgBlGUatKK8YColOhJplPMsIpxCkrGM5yrKVZZw4DyFnKeac5Umftshuu1zl6qSa1vWym6kUaWcTeaybBzYWmIqCIs5-9zy656vrfnowLWyLl0OVaUaMJ2TRIiYxMxX5enVH7oynW38MZLiiGKSUi-H6KZXuTXOWdD7JQiW2-qlr17-VO_t5S6xy2oo9vK3aw_GPfgqK9j8nyTvXx_6yG-a1IsH</recordid><startdate>201805</startdate><enddate>201805</enddate><creator>Le Moigne, M.</creator><creator>Fournier, J.‐P.</creator><creator>Victorri‐Vigneau, C.</creator><creator>Dréno, B.</creator><general>Oxford University Press</general><general>Wiley</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0002-3745-2532</orcidid><orcidid>https://orcid.org/0000-0001-5574-5825</orcidid><orcidid>https://orcid.org/0000-0002-9971-0672</orcidid></search><sort><creationdate>201805</creationdate><title>Oral retinoids and depression: reply from the authors</title><author>Le Moigne, M. ; Fournier, J.‐P. ; Victorri‐Vigneau, C. ; Dréno, B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3909-e1ff92de23bfefa28d3a71f4974c8b4182e6b3b8ca4cab68e887ec87f88a76013</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Cancer</topic><topic>Life Sciences</topic><topic>Mental depression</topic><topic>Retinoids</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Le Moigne, M.</creatorcontrib><creatorcontrib>Fournier, J.‐P.</creatorcontrib><creatorcontrib>Victorri‐Vigneau, C.</creatorcontrib><creatorcontrib>Dréno, B.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>British journal of dermatology (1951)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Le Moigne, M.</au><au>Fournier, J.‐P.</au><au>Victorri‐Vigneau, C.</au><au>Dréno, B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Oral retinoids and depression: reply from the authors</atitle><jtitle>British journal of dermatology (1951)</jtitle><addtitle>Br J Dermatol</addtitle><date>2018-05</date><risdate>2018</risdate><volume>178</volume><issue>5</issue><spage>1224</spage><epage>1224</epage><pages>1224-1224</pages><issn>0007-0963</issn><eissn>1365-2133</eissn><abstract>Linked Articles: Lehloenya and Jessop. Br J Dermatol 2018; 178:1223–1224. Vallerand and Patten. Br J Dermatol 2018; 178:305. Le Moigne et al. Br J Dermatol 2018; 178:278–280</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>29405256</pmid><doi>10.1111/bjd.16429</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-3745-2532</orcidid><orcidid>https://orcid.org/0000-0001-5574-5825</orcidid><orcidid>https://orcid.org/0000-0002-9971-0672</orcidid></addata></record>
fulltext	fulltext
identifier	ISSN: 0007-0963
ispartof	British journal of dermatology (1951), 2018-05, Vol.178 (5), p.1224-1224
issn	0007-0963 1365-2133
language	eng
recordid	cdi_hal_primary_oai_HAL_inserm_02913583v1
source	Wiley Journals; Oxford University Press Journals All Titles (1996-Current)
subjects	Cancer Life Sciences Mental depression Retinoids
title	Oral retinoids and depression: reply from the authors
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T06%3A07%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Oral%20retinoids%20and%20depression:%20reply%20from%20the%20authors&rft.jtitle=British%20journal%20of%20dermatology%20(1951)&rft.au=Le%20Moigne,%20M.&rft.date=2018-05&rft.volume=178&rft.issue=5&rft.spage=1224&rft.epage=1224&rft.pages=1224-1224&rft.issn=0007-0963&rft.eissn=1365-2133&rft_id=info:doi/10.1111/bjd.16429&rft_dat=%3Cproquest_hal_p%3E2042017215%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2042017215&rft_id=info:pmid/29405256&rfr_iscdi=true